Navigated MRI-guided liver biopsies in a closed-bore scanner: experience in 52 patients by Michael Moche et al.
INTERVENTIONAL
Navigated MRI-guided liver biopsies in a closed-bore
scanner: experience in 52 patients
Michael Moche1 & Susann Heinig1 & Nikita Garnov1 & Jochen Fuchs1 &
Tim-Ole Petersen1 & Daniel Seider1 & Philipp Brandmaier1 & Thomas Kahn1 &
Harald Busse1
Received: 15 June 2015 /Revised: 26 August 2015 /Accepted: 28 October 2015 /Published online: 12 November 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract
Objectives To evaluate clinical effectiveness and diagnostic
efficiency of a navigation device for MR-guided biopsies of
focal liver lesions in a closed-bore scanner.
Methods In 52 patients, 55 biopsies were performed. An add-
on MR navigation system with optical instrument tracking
was used for image guidance and biopsy device insertion out-
side the bore. Fast control imaging allowed visualization of
the true needle position at any time. The biopsy workflow and
procedure duration were recorded. Histological analysis and
clinical course/outcome were used to calculate sensitivity,
specificity and diagnostic accuracy.
Results Fifty-four of 55 liver biopsies were performed suc-
cessfully with the system. No major and four minor compli-
cations occurred. Mean tumour size was 23±14 mm and the
skin-to-target length ranged from 22 to 177 mm. In 39 cases,
access path was double oblique. Sensitivity, specificity and
diagnostic accuracy were 88%, 100% and 92%, respectively.
The mean procedure time was 51±12 min, whereas the punc-
ture itself lasted 16±6 min. On average, four control scans
were taken.
Conclusions Using this navigation device, biopsies of poorly
visible and difficult accessible liver lesions could be per-
formed safely and reliably in a closed-bore MRI scanner.
The system can be easily implemented in clinical routine
workflow.
Key Points
• Targeted liver biopsies could be reliably performed in a
closed-bore MRI.
• The navigation system allows for image guidance outside of
the scanner bore.
• Assisted MRI-guided biopsies are helpful for focal lesions
with a difficult access.
• Successful integration of the method in clinical workflow
was shown.
• Subsequent system installation in an existing MRI environ-
ment is feasible.
Keywords Interventional magnetic resonance imaging .
Puncture biopsy . Image-guided biopsy . Stereotactic
techniques . Liver biopsy
Introduction
Diagnostic magnetic resonance imaging (MRI) often provides
superior visualization of small liver lesions that cannot be
detected reliably with computed tomography (CT) or ultra-
sound (US) [1]. Due to the excellent soft tissue contrast, ab-
sence of ionizing radiation and longer-lasting contrast agent
activity, MRI has become an advantageous alternative imag-
ing modality for liver tumours [2] (see Fig. 1). However, as in
any imagingmodality, the specificity ofMRI of liver lesions is
not sufficiently high to preclude biopsy in most cases. While
initial reports of MRI-guided percutaneous biopsies date back
into the late 1980s [3–6], the implementation of these tech-
niques into clinical practice has mostly occurred in the last
decade (Table 1). One of the reasons for this delay was the
later introduction of open MRI systems, which, owing to their
design, provide better access to the patient compared with
conventional closed-bore scanners. However, open MRI units
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are more costly to acquire and maintain, and provide lower
image quality because of their lower magnetic field strength
and inferior field homogeneity. Performing liver biopsies in
conventional closed-bore high-field MRI systems has been
infrequently reported, most likely because of limited patient
access and, hence, the inability to guide the needle under con-
tinuous imaging. Most reports describe a time-consuming it-
erative approach [7–9], where after a rough assessment for an
access point and orientation, the needle is stepwise guided to
the lesion by multiple cycles of scanning and needle position
correction outside the magnet.
An easy-to-use navigation system allowing fast and accu-
rate determination of the skin entry point and targeting of the
lesion in one step outside the bore, would simplify the above-
mentioned approach. We report our clinical experience with
liver biopsies using an add-on navigation device for a closed-
bore 1.5 T MRI scanner and evaluate the system’s functional-
ity, effect on workflow and diagnostic accuracy.
Materials and methods
Study population
The study was approved by the local institutional review
board (University of Leipzig, register no. 344-2007) and writ-
ten informed consent was obtained from each patient.
Between July 2008 and February 2012, 52 patients underwent
Fig. 1 A 63-year old patient with a small lesion in liver segment VII was
referred for MRI-guided biopsy due to lesion invisibility on CT (left).
With MRI (VIBE) the lesion (arrowhead) was clearly depicted without
contrast agent administration (right). The double oblique access path was
131 mm. With the help of the navigation device a coaxial needle is
inserted before the lesion. Through the needle a 16 G semiautomatic
biopsy gun is placed. The Tru-Cut® tip of the biopsy gun is recognizable
(arrow) at the border of the lesion. The histology analysis revealed a
non-Hodgkin’s lymphoma
Table 1 Literature summary of magnetic resonance-guided interventions

















Fischbach et al., 2011 [15] 103/50 - 18 - - 15 20 yes
Zangos et al., 2009 [24] 322/126 - - 0.98 78 - - no
Wide-bore MRI
Hoffmann et al., 2012 [22] 38/19 134.1 70.6 0.89 71 27 2 yes/no*
Kühn et al., 2010 [18] 47/44 42 9 0.94 108 34 6 no
Stattaus et al., 2008 [17] 25/25 48 19 0.96 93 23 2 yes
Closed-bore MRI
Das et al., 2010 [9] 10/4 59.7 20-25 - - 25 - no
Langen et al., 2002 [8] 10/8 48 - - 70 62 1 no
Salomonowitz, et al., 2001 [7] 250/42 - 21 0.93 - - 5 no
Moche et al., 2010 [19] 6/1 - - - - - - no
*Moche et al., this work 55/55 51 16 0.92 99 23 4 no
MRF magnetic-resonance fluoroscopy
* MRF was applied in nine cases
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MRI-guided needle biopsies of liver lesions using an add-on
navigation system (iMRI Navigator®, Localite, St. Augustin,
Germany). We studied 30 males and 22 females with a mean
age of 57.2±13.8 years (range: 27–82 years) and a mean body
mass index (BMI) of 26.6±5.1 kg/m2 (range: 17.6–40.3). The
patients were scheduled for MRI-guided biopsies based on the
following indications: significantly improved visibility of the
suspect lesion on MR images (n=23) compared with CT
(Fig. 1) and US, difficult double oblique access path (n=39)
or patient age under 50 years (n=17).
Exclusion criteria were age under 18 years, debilitated gen-
eral patient condition, uncorrectable or marginally correctable
coagulation disorder, and general contraindications for MRI.
Navigation technique
Forty interventions were performed by an interventional radi-
ologist (M.M.) with 10 years of experience; the following 15
interventions were carried out by two resident radiologists
(J.F., TO.P.) with 2 years of experience under supervision. A
dedicated navigation system [10] with optical tracking and
automatic patient registration based on MRI-marker localiza-
tion [11, 12] was implemented. This procedure is required
only once per session but can be repeated as often as neces-
sary. The instrument manipulation is displayed in a
multiplanar virtual navigation scene on a large in-room screen.
The setup of the navigation components is shown in Fig. 2.
Biopsy procedure
System setup and patient preparation
All biopsies were performed in a stable and comfortable
supine patient position (Fig. 2). To improve diagnostic
image quality, two 19-cm loop coils (Siemens Healthcare,
Erlangen, Germany) were placed on the patients’ abdomen
and right side, which were used in combination with the
spine coil. Two holding arms were mounted on the patient
table. The holding arm opposite the access site was aligned
to enable mounting of the reference marker board (RMB)
as close as possible to the isocentre position of the MRI-
scanner. The proper line-of-sight to the camera was en-
sured in out-of-magnet position. The RMB is positioned
in a way that it cannot be displaced by patients’ breathing
movements and does not interfere with sterile instruments
during the intervention. A special front-end module (de-
veloped in collaboration with the authors and Invivo
Germany GmbH, Schwerin, Germany), which is used to
hold, adjust and lock the coaxial needle in the intended
biopsy position, is attached to a holding arm on the inter-
vention site (Fig. 2). Needle movement is visualized in the
navigation display (Fig. 3) with an almost real-time refresh
rate of 4 frames/s and no recognizable delay.
Patient analgesia/sedation was induced by intravenous ad-
ministration of 3–5 mg piritramide and 2–5 mg midazolam
prior to the intervention. To minimize errors caused by respi-
ratory motion, each patient underwent a short breath-hold
training before the intervention. This exercise comprised five
identical breathing commands with breath-hold phases in mild
inspiration, corresponding to commands given during the
procedure.
Imaging
All interventions were performed in a conventional closed-
bore 1.5 T MRI scanner (Magnetom Symphony®, Siemens)
with a bore diameter of 60 cm and a gantry length of 150 cm.
For MR-marker localization, a short scan sequence with a low
flip angle and large field of view (FOV) in three standard
views was applied using the integrated body coil. This se-
quence aimed to provide marker projection images within a
large volume (300×300×300 mm3) and minimal signal con-
tribution from the patient, as previously described [10]. For
procedure planning, transverse images were acquired with
volume-interpolated breath-hold examination (VIBE), half-
Fourier single-shot turbo spin echo (HASTE), as well as true
Fig. 2 Setup of the navigation components. A compact instrument
tracker (B) (Localite) with a set of three spherical retro-reflective optical
markers (arrow head; NDI,Waterloo, ON, Canada) is attached to the base
of the coaxial needle. The needle with the tracker is fixed within the front-
end-module (A). The main feature of the front-end module is a two-piece
ball clamped in a gripping jaw into which the biopsy needle is inserted,
allowing fixation in the appropriate position and orientation. Partial re-
lease of the ball enables the needle to remain stabilized in situ but allows it
to follow patients’ respiratory motion and with that to avoid injury to the
liver. In case of emergency, the ball can quickly be detached from the
front-end module, leaving the needle in situ. Optical real-time tracking of
the instrument is realized through a movable 3D infrared camera (Polaris
Spectra®, NDI) that also couples a second reference set of the above-
mentioned optical markers on a reference marker board (C) that remains
fixed to the patient table and also features a set of MR-visible markers
(arrow) that are used for registration of the navigation scene
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fast imaging with steady precession (TRUFI) (Table 2), using
the abovementioned combination of loop and spine coils. In
case the lesion was not clearly visible in the planning images,
10 ml of the liver-specific contrast agent gadoxetate disodium
(Primovist®, Bayer HealthCare Pharmaceuticals, Berlin,
Germany) was administered intravenously approximately
15 min prior to the intervention to improve negative contrast
in the VIBE-sequence.
During imaging, care was taken to give the breath-hold
commands as trained before to ensure an even breathing pat-
tern and breath-hold.
The sequence with the optimum lesion visibility was
used as the dataset for navigation and as standard for
control imaging.
Navigation procedure
To begin navigation, marker and diagnostic images from the
MRI scanner’s computer were interactively sent to the navi-
gation workstation, the software of which features modules
for graphical access planning and navigation [10]. After been
detected by the system, the instrument tracker was used to
quickly define the puncture site with an unsterile needle.
The skin location was marked, disinfected and covered with
sterile drapes. After local anaesthesia with 10–15 ml lido-
caine, we made a small cutaneous incision with a scalpel.
Under real-time navigation, the tip of the sterile coaxial needle
(16G coaxial needle, Invivo or Somatex, SOMATEX®
Medical Technologies GmbH, Teltow, Germany) attached to
a sterile tracker was guided to the prepared incision site and
angulated with respect to the target lesion. The access path
was chosen in a way to avoid damage to pleura or adjacent
organs. After giving the breath-hold command (in inspiration,
as described above), the needle was rapidly inserted along the
planned approach guided by the navigation images. At any
time, the real needle position in situ could be verified by a
control scan for which the patient table with the instrument in
place was moved into the magnet. The new images could be
immediately used to update the navigation scene without re-
peating patient registration.
Sampling and post-procedure
After successfully approaching the lesion with the coaxial
needle, multiple tissue samples were obtained with the proper
biopsy system (18G semiautomatic biopsy gun, Invivo). After
Fig. 3 Screenshot of the navigation scene. Reformatted MR images of
the planning dataset are interactively shown either instrument-related in-
plane (a), 90° in-plane (b) or perpendicular to the instrument (c). On a and
b the green lines indicate the needle in full length and the blue lines show
its trajectory to facilitate orientation to the target (arrow head). For better
orientation, a 3D reconstruction is also provided (d)
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final retraction of the needle, control imaging with VIBE and
HASTE was performed. The standard post-operation proce-
dure in our hospital recommends the overnight stay. The pa-
tients were hospitalized over 24 h after the intervention to rule
out potential complications, as graded by the classification of
the Society of Interventional Radiology [13]. In our experi-
ence, the biopsies could be done as an outpatient treatment
with 2 h of post-interventional monitoring and medical check-
up before discharge.
Evaluation
Each procedure was documented using a standard protocol
form, and the logs were evaluated retrospectively. All dura-
tions, imaging sequences, complications, contrast administra-
tion and number of samples taken were recorded. Times for
individual steps were rounded to full minutes. The following
procedure steps were evaluated: (i) system preparation, (ii)
setup, (iii) planning, (iv) entry determination, (v) puncture
preparation, (vi) intervention and (vii) control imaging (Fig. 4).
Tumour size and path length were evaluated using the scan-
ner software. Follow-up measurements of clinical values as
well as MRI or CTwere performed 3 and 6 months after inter-
vention. Statistical tests were performed using Pearson correla-
tion analysis with a statistical significance level of P<0.05.
The biopsy results were classified as true-negative if the
samples from subsequent surgery revealed a non-malignant
lesion or if the lesion was non-progressive on a subsequent
MRI or CT examination for 6 months. The results were true-
positive if histology confirmed malignancy. False-negative
results were stated either when 6-month follow-up imaging
revealed clear tumour progression or when histology after
surgery was positive for malignancy.
Results
Imaging and targeting
In 52 patients, 55 liver biopsies were performed using the
navigation device. During one procedure, the navigation was
technically unsuccessful and the puncture was continued free-
hand. Most lesions were in liver segment VIII (Table 3). The
VIBE sequence (51/55) provided the best visibility of the le-
sions. In 37 cases, contrast agent was administrated. The mean
lesion size was 23±14 mm (range: 5–90 mm). The skin-to-
target distances ranged from 22 to 177 mm (mean: 99±
38 mm). No correlation was found between tumour size (r=
−0.050, P=0.73) or depth (r=0.073, P=0.61) and intervention
time. In 39 cases, the chosen access path was double oblique.
Histological results
On average, 4±1 samples (range: 2–7) were taken with each
biopsy. Out of 55 biopsies, 28 revealed malignant lesions
Table 2 Details of diagnostic
imaging sequences Sequence Parameters




VIBE 3.3/1.3 15 64 3 17 s
HASTE 1100/120 150 19 8 21 s
TRUFI 4.3/2.2 58 19 8 18 s
TR repetition time, TE echo time, VIBE volume-interpolated breath-hold examination, HASTE half-Fourier
single-shot turbo spin echo, TRUFI true fast imaging with steady precession
Fig. 4 Mean duration of procedural steps in minutes. (i) system
preparation: placement of the infrared camera and the in-room screen,
starting and booting all components; (ii) setup: patient positioning,
mounting of the imaging coils, holding arms and reference marker
board; (iii) planning: planning imaging, marker imaging and
localization, data transfer to the navigation workstation, starting the
navigation scene; (iv) entry determination: initial rough navigation with
unsterile instrument tracker; (v) puncture preparation: disinfection and
sterile covering; (vi) intervention: local anaesthesia, first needle
insertion to sampling, final control imaging; (vii) control imaging:
intermediate control imaging including patient-table travel periods
(except last control), and sequence duration. Error bars indicate standard
deviations
Table 3 Lesion positions within the liver segmentsa
Segment S1 S2 S2/3 S3 S4 S5 S5/6 S6 S6/7 S7 S7/8 S8
Lesions, n 1 5 5 4 5 7 5 5 2 5 0 11
a Liver segments are defined according to Couinaud
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(Table 4). In total, four collected samples were false-negative:
one biopsy could not be reliably examined histologically be-
cause the sample was highly fragmented, but further clinical
follow-up revealed a hepatocellular carcinoma. In the second
false-negative case, the lesion was small (6 mm) and had a
skin-to-target distance of 106 mm; two further biopsies could
not confirm malignancy, despite an advanced stage of the
diseases (both patients died before the 6-month follow-up
from cervix and pancreatic carcinoma, respectively). Two
histological results suspected as malignant were excluded
from the evaluation due to missing the 6-month follow-up.
Overall sensitivity, specificity and accuracy were 88 %,
100 % and 92 %, respectively (Table 5).
Workflow
The average duration of the procedural steps is shown in
Fig. 4. The procedure time was defined as the sum of all
steps except system preparation and was 51±12 min on
average (range: 24–75 min). The system preparation (i) took
6±3 min. The duration of the setup (ii) was 9±5 min on
average. The mean duration of the planning phase (iii) was
9±6 min. The entry point determination (iv) took 2±2 min
(range: 1–7 min). The mean intervention (vi) time including
final control imaging was 16±6 min (range: 4–35 min). The
number of scans for needle position control per session
ranged from 1 to 15 (4±1 on average)'. The longest proce-
dure duration was 75 min overall time, with 35 min inter-
vention time, and 15 control scans. This biopsy was per-
formed on a suspicious lesion in segment 1 with the longest
skin-to-target distance of 177 mm and a difficult paracaval
location (Fig. 5).
Complications
No major complications were documented for the 55
interventions. Minor complications occurred in four
(7.3 %) patients. In two cases, one narrow perihepatic
and one subcutaneous haematoma were detected on final
control imaging. Neither showed progression on US af-
ter 24 h. Two patients experienced moderate abdominal
pain, nausea and vomiting, which regressed completely
after appropriate medication which did not prolong the
hospitalization period.
Discussion
For lesions that cannot be visualized reliably with US or CT,
MRI can serve as an excellent imaging modality because of its
high soft-tissue contrast and longer lasting contrast agent ef-
fect [14]. Nevertheless, only a few studies have reported on
MRI-guided biopsies in the widely available diagnostic scan-
ner environments. Within this study, 54 liver biopsies were
successfully performed using a new targeting system to over-
come limited patient access in a conventional diagnostic MRI
system. The accuracy, safety and duration of the procedure
were found to be acceptable for clinical routine use.
Most common MRI scanners have a bore diameter of
60 cm and a gantry length of 140 cm and above, which
Table 4 Histology results of 55 biopsies in 52 patients
Result
Hepatocellular carcinoma 9 (8)
Adenocarcinoma/metastasis 9 (0)
Other metastases 10 (1)
Adenoma 3 (0)
Haemangioma 2 (0)





Numbers in parentheses are pathological findings with liver cirrhosis
Table 5 Diagnostic







TP true positive, TN true negative,FP false
positive, FN false negative
Fig. 5 An example of a difficult-to-approach paracaval lesion
(arrowhead) located in segment 1 in a 72-year-old patient with liver
cirrhosis. The histopathological result confirmed hepatocellular
carcinoma. The image shows a maximum intensity projection
reconstructed from a volume-interpolated breath-hold examination
(VIBE) sequence after contrast administration with angulation along to
needle pathway
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limits patient access during image acquisition. Therefore, in
contrast to CT, US or open MRI, with closed-bore MRI
needle insertion under continuous imaging, so-called MR-
fluoroscopy (MRF), is not feasible. On the other hand,
MRF is especially advantageous for biopsies of uncoopera-
tive patients [15, 16]. However, the diagnostic accuracy
achieved with MRF in open or wide-bore systems does not
appear higher than the accuracy reported for biopsies in
closed-bore scanners without MRF (Table 1). The wide-
bore system used by Stattaus et al. [17] enables needle in-
sertion under MRF. However, this system and vertical open
MR systems are no longer commercially available. The hor-
izontal open scanners can have major disadvantages for pro-
cedures involving the left lobe of the liver [15]. Moreover,
due to the lower magnetic field strength, and, thus, the infe-
rior diagnostic usability, such open MRIs are becoming rar-
er. The wide-bore 3 T magnet used in previous work [18]
offers a 70-cm bore, but with a 170-cm gantry length, the
system is impractical for needle guidance under MRF.
Currently, there are only a few reports of liver biopsies
performed in closed-bore high-field MRI scanners. In a small
study, Das et al. [9] reported an iterative approach allowing
liver biopsies to be performed within approximately 1 h.
Using a similar technique, Salomonowitz et al. [7] have per-
formed 42 liver punctures; however, the authors did not report
procedure durations. In one case, Moche et al. [19] reported
application of a robotic system in a closed-bore MRI scanner
for liver biopsy. Our study describes the clinical use of a nav-
igation device in a relatively large number of liver punctures
in a closed-bore MRI scanner. The system features flexibility
in terms of integration into different common MRI environ-
ments, even in patients with a BMI of up to 40 kg/m2, as
included in this study. However, the system setup prior to
the procedure requires additional time. With a mean interven-
tion time of 51min (including all steps from patient placement
to final control scan), our MRI-guided procedures took longer
than CT-guided procedures [20, 21], evenwith an experienced
team. However, our technique did not require significantly
more time than procedures guided by MRF. In a study
employing a wide-boreMRI system, even a median procedure
time of approximately 134 min has been reported [22], which
exceeds our results. Furthermore, the procedure steps have not
been equally defined in different studies. Compared with
scarcely described procedures using an iterative approach
[9], the overall procedure times are similar to those reported
here, whereas the actual intervention time appears to be
shorter. It can be assumed that the time for setup and planning
could be reduced by routine and sequential use of the system.
A long skin-to-target distance and small lesion size are
generally indicative of the complexity of the intervention.
The mean skin-to-target distance in our study was 99 mm
and was longer than 100 mm in 32 % of cases. These values
are higher than mean distances reported by the most groups
(Table 1). This is especially noteworthy in view of the fact that
iterative image-controlled placement of long needles in a
closed-bore scanner is more difficult than in an open MRI
system. Langen et al. [8] emphasized a long biopsy path being
a limiting factor in a 60-cm wide gantry.
The mean diameter of the lesions was 23 mm, with 10 %
smaller than 10 mm. The control imaging immediately before
sampling was performed using the T1-weighted VIBE se-
quence, which, in conjunction with gadoxetate-based contrast
agent in the majority of cases, allowed for reliable visualiza-
tion of the slim Tru-Cut® needle tip in the lesion (Fig. 1). It is
expected that such imaging will ensure reliable sampling. In
contrast to the results of Hoffmann et al. [22], our analysis of
the influence of the skin-to-target distance or lesion size on the
procedure time or accuracy revealed no statistically significant
correlations.
The accuracy of 92 % assessed in our study is comparable
with earlier reports for MRI -guided interventions [17, 18, 23,
24], as well as with the accuracy reached by US and CT
guidance [25–28]. It should be noted, however, that for our
study only those patients were selected who could not be
biopsied under CT or US guidance. Thus, it can be assumed
that this selection of difficult cases would have led to a lower
accuracy when compared with a randomized cohort.
The safety of MRI-guided biopsies is emphasized by our
low complication rate, which is in line with most reports [7–9,
15–19, 22, 23]. There were no major complications docu-
mented, neither at our site nor in other studies, except for
two cases reported from Zangos et al. [24].
Unlike neurosurgical and some other applications, the use
of similar navigation techniques in organs subject to respira-
tory motion is controversial. Because of the lack of fluoro-
scopic imaging, the actual needle position cannot be con-
trolled second-by-second. In case of patient movement or dif-
fering respiratory phases between the imaging data used for
navigation and the puncture itself, the needle could be placed
considerably off-target. One possibility to address this issue is
motion compensation respiratory gating. This technique uses
for example optical or other tracking techniques to follow
abdominal wall movement and simulates the respiratory mo-
tion in the liver, applying a complex algorithm [29]. These
authors concluded, however, that because of the lack of fluo-
roscopic imaging, motion compensation cannot be ensured
with absolute certainty.
A potential drawback of this work is the fact that the
employed system has not yet been approved for commercial
dissemination, although the local institutional review board
admitted this study. Another limitation is the lack of a control
group treated with the conventional technique described by
other authors [7–9]. However, due to the comparatively long
mean access path in our patients and the limited space in a 60-
cm bore, the needle should have been inserted quite deeply
outside the scanner at once without any image guidance. For
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that reason the authors estimated the risk for a possible control
group to be too high and decided using the system in all cases.
The presented system is less costly in comparison with
dedicated interventional MRI environments. However, even
with this technique liver biopsies are significantly more cost-
intensive than CT- and especially US-guided procedures.
Therefore careful selection of the patients is essential for the
optimal use of this approach.
Conclusion
An approach combining brief respiratory training, navigated
needle feed with automatic patient registration and immediate
control imaging has proven to be successful for liver biopsies.
Access to the patient outside the bore features maximum pa-
tient comfort and allows interventional radiologists to take
samples with high diagnostic accuracy, even for overweight
patients. Relatively short procedure durations and the flexibil-
ity of the presented add-on solution suggest integrating it into
the clinical workflow in a conventional diagnostic high-field
MRI environment, especially for biopsies of suspect lesions,
which cannot be detected with US or CT, or are difficult to
access.
Acknowledgments MMand SH contributed equally to the manuscript.
The scientific guarantor of this publication is Michael Moche, MD
from the Department of Diagnostic and Interventional Radiology, Leipzig
University Hospital, Leipzig, Germany. The authors of this manuscript
declare following relationships with companies whose products or ser-
vices may be related to the subject matter of the article: Non-remunerated
cooperation with Localite GmbH in the development of the navigation
software, and non-remunerated cooperation with Invivo GmbH in the
development of the MR-compatible needle holder.
The authors state that this work has not received any funding. No
complex statistical methods were necessary for this paper. Institutional
Review Board approval was obtained. Written informed consent was
obtained from all patients in this study. No study subjects or cohorts have
been previously reported.
Methodology: prospective, performed at one institution.
Open Access This article is distributed under the terms of the Creative
Commons Attribution-NonCommercial 4.0 International License (http://
creativecommons.org/licenses/by-nc/4.0/), which permits any noncom-
mercial use, distribution, and reproduction in any medium, provided
you give appropriate credit to the original author(s) and the source, pro-
vide a link to the Creative Commons license, and indicate if changes were
made.
References
1. Hammerstingl R, Huppertz A, Breuer J, Balzer T, Blakeborough A,
Carter R et al (2008) Diagnostic efficacy of gadoxetic acid
(Primovist)-enhanced MRI and spiral CT for a therapeutic strategy:
comparison with intraoperative and histopathologic findings in fo-
cal liver lesions. Eur Radiol 18:457–467
2. Fowler KJ, Brown JJ, Narra VR (2011) Magnetic resonance imag-
ing of focal liver lesions: approach to imaging diagnosis.
Hepatology 54:2227–2237
3. Lufkin R, Duckwiler G, Spickler E, Teresi L, Chang M, Onik G
(1988) MR body stereotaxis: an aid for MR-guided biopsies. J
Comput Assist Tomogr 12:1088–1089
4. Lufkin R, Teresi L, Chiu L, HanafeeW (1988) A technique forMR-
guided needle placement. AJR Am J Roentgenol 151:193–196
5. Mueller PR, Stark DD, Simeone JF, Saini S, Hahn PF, Steiner E
et al (1989) Clinical use of a nonferromagnetic needle for magnetic
resonance-guided biopsy. Gastrointest Radiol 14:61–64
6. Schmitt R, Helmberger T, Fellner F, Obletter N (1993) The
marking of nonpalpable breast tumors in MRT. Röfo 159:
484–486
7. Salomonowitz E (2001) MR imaging-guided biopsy and therapeu-
tic intervention in a closed-configuration magnet: single-center se-
ries of 361 punctures. AJR Am J Roentgenol 177:159–163
8. Langen H-J, Kugel H, Landwehr P (2002) MR-guided core biop-
sies using a closed 1.0 T imager. First clinical results. Eur J Radiol
41:19–25
9. Das CJ, Goenka AH, Srivastava DN (2010) MR-guided abdominal
biopsy using a 1.5-Tesla closed system: a feasibility study. Abdom
Imaging 35:218–223
10. Busse H, Garnov N, Thörmer G, Zajonz D, Gründer W, Kahn T,
Moche M (2010) Flexible add-on solution for MR image-guided
interventions in a closed-bore scanner environment. Magn Reson
Med 64:922–928
11. Garnov N, Thörmer G, Trampel R, Gründer W, Kahn T, Moche M,
Busse H (2011) Suitability of miniature inductively coupled RF
coils as MR-visible markers for clinical purposes. Med Phys 38:
6327–6335
12. Busse H, Trampel R, Gründer W, Moche M, Kahn T (2007)
Method for automatic localization of MR-visible markers using
morphological image processing and conventional pulse se-
quences: feasibility for image-guided procedures. J Magn Reson
Imaging 26:1087–1096
13. Gupta S, Wallace MJ, Cardella JF, Kundu S, Miller DL, Rose SC
et al (2010) Quality improvement guidelines for percutaneous nee-
dle biopsy. J Vasc Interv Radiol 21:969–975
14. König CW, Trübenbach J, Fritz J, Lauer UM, Claussen CD, Pereira
PL (2004) Contrast enhanced MR-guided biopsy of hepatocellular
carcinoma. Abdom Imaging 29:71–76
15. Fischbach F, Bunke J, Thormann M, Gaffke G, Jungnickel K,
Smink J (2011) MR-guided freehand biopsy of liver lesions
with fast continuous imaging using a 1.0-T open MRI scan-
ner: experience in 50 patients. Cardiovasc Intervent Radiol
34:188–192
16. Stattaus J, Maderwald S, Forsting M, Barkhausen J, Ladd ME
(2008) MR-guided core biopsy with MR fluoroscopy using a short,
wide-bore 1.5-Tesla scanner: feasibility and initial results. J Magn
Reson Imaging 27:1181–1187
17. Stattaus J, Maderwald S, Baba HA, Gerken G, Barkhausen J,
Forsting M et al (2008) MR-guided liver biopsy within a short,
wide-bore 1.5 Tesla MR system. Eur Radiol 18:2865–2873
18. Kühn J-P, Langner S, Hegenscheid K, Evert M, Kickhefel A,
Hosten N et al (2010) Magnetic resonance-guided upper ab-
dominal biopsies in a high-field wide-bore 3-T MRI system:
feasibility, handling, and needle artefacts. Eur Radiol 20:
2414–2421
19. Moche M, Zajonz D, Kahn T, Busse H (2010) MRI-guided proce-
dures in various regions of the body using a robotic assistance
system in a closed-bore scanner: preliminary clinical experience
and limitations. J Magn Reson Imaging 31:964–974
20. Welch TJ, Sheedy PF, Johnson CD, Johnson CM, Stephens DH
(1989) CT-guided biopsy: prospective analysis of 1,000 procedures.
Radiology 171:493–496
Eur Radiol (2016) 26:2462–2470 2469
21. Silverman SG, Tuncali K, Adams DF, Nawfel RD, Zou KH,
Judy PF (1999) CT fluoroscopy-guided abdominal interven-
tions: techniques, results, and radiation exposure. Radiology
212:673–681
22. Hoffmann R, Thomas C, Rempp H, Schmidt D, Pereira PL,
Claussen CD et al (2011) Performing MR-guided biopsies in clin-
ical routine: factors that influence accuracy and procedure time. Eur
Radiol 22:663–671
23. Zangos S, Kiefl D, Eichler K, Engelmann K, Heller M, Herzog C
et al (2003) MR-guided biopsies of undetermined liver lesions:
technique and results. Röfo 175:688–694
24. Zangos S, Müller C, Mayer F, Naguib N, Nour-Eldin N-E,
Hansmann ML et al (2009) Retrospektive Analyse der 5-Jahres-
Ergebnisse von MRT-gesteuerten Biopsien im Niederfeldsystem.
Röfo 181:658–663
25. Haage P, Piroth W, Staatz G, Adam G, Günther RW (1999) CT-
guided percutaneous biopsies for the classification of focal liver
lesions: a comparison between 14 G and 18 G puncture biopsy
needles. Röfo 171:44–48
26. Yu SC, Liew CT, Lau WY, Leung TW, Metreweli C (2001) US-
guided percutaneous biopsy of small (< or=1-cm) hepatic lesions.
Radiology 218:195–199
27. Chojniak R, Isberner RK, Viana LM, Yu LS, Aita AA, Soares FA
(2006) Computed tomography guided needle biopsy: experience
from 1,300 procedures. Sao Paulo Med J 124:10–14
28. Stattaus J, Kühl H, Hauth EA, Kalkmann J, Baba HA, Forsting M
(2007) Liver biopsy under guidance of multislice computed tomog-
raphy: comparison of 16G and 18G biopsy needles. Radiologe 47:
430–438
29. Maier-Hein L, Müller SA, Pianka F, Wörz S, Müller-Stich
BP, Seitel A et al (2008) Respiratory motion compensation
for CT-guided interventions in the liver. Comput Aided Surg
13:125–138
2470 Eur Radiol (2016) 26:2462–2470
